세계의 임상 검사 서비스 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Clinical Laboratory Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 6,828,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 9,972,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,613,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

세계 임상 검사 서비스 시장 규모는 2025년에 2,975억 달러에 이르고, 2025-2032년의 예측 기간 동안 4.2%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 3,968억 달러에 달할 것으로 예측됩니다.

임상 검사 서비스는 헬스케어 생태계에 필수적인 요소로, 의료 의사결정에 정보를 제공하고 환자의 예후를 개선하는 중요한 진단, 모니터링 및 예방 서비스를 제공합니다. 이러한 서비스에는 일상적인 혈액 검사, 미생물 검사, 병리 검사, 유전자 진단, 특수 분자진단 등 다양한 유형의 검사가 포함됩니다. 임상 검사 서비스 시장은 병원, 독립계 검사실, 학술연구기관, 진단센터 등을 대상으로 합니다. 시장 확대의 원동력은 헬스케어에 대한 인식 증가, 질병 조기 발견에 대한 수요 증가, 만성 질환 및 감염성 질환에 대한 전 세계 부담 증가입니다.

세계 임상 검사 서비스 시장은 당뇨병, 심혈관 질환, 암과 같은 만성 질환의 발병률 증가, 지속적인 진단 검사 및 건강 모니터링의 필요성 증가 등 몇 가지 중요한 요인에 의해 촉진되고 있습니다. 정확한 진단 데이터에 의존하는 개인 맞춤형 의료에 대한 수요 증가도 시장 수요를 촉진하고 있습니다. 자동화, 인공지능, 차세대 염기서열 분석(NGS)과 같은 기술 발전은 검사 정확도를 높이고, 검사 시간을 단축하며, 검사실 워크플로우의 효율성을 개선합니다. 또한, 고령 인구 증가와 신흥 경제국의 의료비 지출 증가가 시장 개척에 기여하고 있습니다.

유망한 전망에도 불구하고, 임상 검사 서비스 시장은 높은 운영 비용, 상환 문제, 규제의 복잡성 등 여러 가지 문제에 직면해 있습니다. 검사 시설은 엄격한 품질 기준과 인증 기준을 준수해야 하며, 이는 경영 자원을 압박하고 소규모 검사 시설과 독립 검사 시설의 진입을 제한할 수 있습니다. 또한, 지연된 보험 상환과 지역 간 보험 적용 범위의 통일성 부족은 적시에 진단을 받는 환자의 접근성을 저해할 수 있습니다. 또한, 특히 유전자 검사 및 개인화 검사의 데이터 프라이버시 문제도 신뢰 구축과 규제 준수를 보장하기 위해 해결해야 할 과제입니다.

임상 검사 서비스 시장은 디지털 전환, 인공지능의 통합, 서비스 소외 지역으로의 확장을 통해 많은 성장 기회를 제공합니다. 원격 의료 및 재택 검체 채취 서비스의 도입이 증가함에 따라 편의성이 향상되고 진단 검사에 대한 접근성이 확대될 것입니다. 아시아태평양, 라틴아메리카, 아프리카의 신흥 시장들은 의료 인프라에 대한 투자를 늘리고 있으며, 이는 검사 서비스 제공업체들에게 새로운 길을 열어주고 있습니다. 질병 감시와 발병 대응을 강화하기 위한 공중보건 기관과 민간 진단 실험실의 파트너십은 더 많은 확장의 문을 열어줄 것입니다. 또한, 예방의학 및 웰니스 검사 동향은 임상 실험실에 새로운 서비스 모델과 수익원을 제공합니다.

세계의 임상 검사 서비스 시장에 대해 조사했으며, 검사 유형별/공급자 유형별/용도별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위와 정의
• 시장 역학
• 거시경제 요인
• COVID-19의 영향 분석
• 예측 요인 - 관련성과 영향

제3장 부가가치 인사이트

제4장 세계의 임상 검사 서비스 시장 전망

• 주요 하이라이트
• 시장 규모 분석과 예측
  • 과거 시장 규모(10억 달러) 분석, 2019년-2024년
  • 현재 시장 규모(10억 달러) 분석과 예측, 2025년-2032년
• 세계의 임상 검사 서비스 시장 전망 : 검사 유형별
  • 서론/주요 조사 결과
  • 과거 시장 규모(10억 달러) 분석, 검사 유형별, 2019년-2024년
  • 현재 시장 규모(10억 달러) 분석과 예측, 검사 유형별, 2025년-2032년
    • 임상화학
    • 의료 미생물학
    • 유전자 검사
    • 혈액학
    • 인간 및 종양 유전학
    • 세포학
    • 기타
  • 시장의 매력 분석 : 검사 유형별
• 세계의 임상 검사 서비스 시장 전망 : 프로바이더 유형별
  • 서론/주요 조사 결과
  • 과거 시장 규모(10억 달러) 분석, 프로바이더 유형별, 2019년-2024년
  • 현재 시장 규모(10억 달러) 분석과 예측, 프로바이더 유형별, 2025년-2032년
    • 병원 검사실
    • 독립 연구소
    • 표준 검사실
  • 시장의 매력 분석 : 프로바이더 유형별
• 세계의 임상 검사 서비스 시장 전망 : 용도별
  • 서론/주요 조사 결과
  • 과거 시장 규모(10억 달러) 분석, 용도별, 2019년-2024년
  • 현재 시장 규모(10억 달러) 분석과 예측, 용도별, 2025년-2032년
    • 바이오 분석 및 레버러토리 화학 서비스
    • 독성 시험 서비스
    • 세포 및 유전자 치료 관련 서비스
    • Drug Discovery & Development 서비스
    • 전임상 및 임상시험 관련 서비스
    • 기타
  • 시장의 매력 분석 : 용도별

제5장 세계의 임상 검사 서비스 시장 전망 : 지역별

• 주요 하이라이트
• 과거 시장 규모(10억 달러) 분석, 지역별, 2019년-2024년
• 현재 시장 규모(10억 달러) 분석과 예측, 지역별, 2025년-2032년
  • 북미
  • 유럽
  • 동아시아
  • 남아시아 및 오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제6장 북미의 임상 검사 서비스 시장 전망

제7장 유럽의 임상 검사 서비스 시장 전망

제8장 동아시아의 임상 검사 서비스 시장 전망

제9장 남아시아 및 오세아니아의 임상 검사 서비스 시장 전망

제10장 라틴아메리카의 임상 검사 서비스 시장 전망

제11장 중동 및 아프리카의 임상 검사 서비스 시장 전망

제12장 경쟁 구도

• 시장 점유율 분석, 2025년
• 시장 구조
• 기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
  • Laboratory Corporation of America Holdings(LabCorp)
  • QIAGEN NV
  • Charles River Laboratories International, Inc
  • Eurofins Scientific SE
  • Quest Diagnostics Incorporated
  • OPKO Health, Inc
  • Siemens Medical Solutions USA, Inc.
  • NeoGenomics Laboratories
  • Fresenius Medical Care
  • ARUP Laboratories
  • Sonic Healthcare
  • SYNLAB International GmbH
  • Mayo Clinic Laboratories
  • Unilabs
  • BioReference Laboratories, Inc.
  • Genomic Health(part of Exact Sciences)
  • Intertek Group plc
  • ACM Global Laboratories
  • Cerba HealthCare
  • Medicover Diagnostics
  • KingMed Diagnostics
  • DaVita Clinical Research
  • Amedes Holding GmbH

제13장 부록

LSH

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical laboratory services. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical laboratory services market from 2025 to 2032.

Key Insights:

• Clinical Laboratory Services Market Size (2025E): USD 297.5 Billion
• Projected Market Value (2032F): USD 396.8 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 4.2%

Clinical Laboratory Services Market - Report Scope:

Clinical laboratory services are essential to the healthcare ecosystem, providing critical diagnostic, monitoring, and preventive services that inform medical decisions and improve patient outcomes. These services encompass a wide array of testing types, including routine blood tests, microbiology, pathology, genetic diagnostics, and specialized molecular diagnostics. The clinical laboratory services market caters to hospitals, independent laboratories, academic and research institutions, and diagnostic centers. Market expansion is driven by rising healthcare awareness, increasing demand for early disease detection, and the growing burden of chronic and infectious diseases across the globe.

Market Growth Drivers:

The global clinical laboratory services market is fueled by several key factors, including the rising incidence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, which necessitate ongoing diagnostic testing and health monitoring. The increasing demand for personalized medicine, which relies on precise diagnostic data, also boosts market demand. Technological advancements such as automation, artificial intelligence, and next-generation sequencing (NGS) enhance test accuracy, reduce turnaround times, and improve laboratory workflow efficiency. Additionally, the growing elderly population and increasing health expenditure across developed and emerging economies further contribute to market growth.

Market Restraints:

Despite its promising outlook, the clinical laboratory services market faces several challenges, including high operational costs, reimbursement issues, and regulatory complexities. Laboratories are required to comply with stringent quality and accreditation standards, which may strain resources and limit the participation of smaller or independent labs. Moreover, delays in reimbursement and lack of uniformity in insurance coverage across regions can hinder patient access to timely diagnostics. Data privacy concerns, especially in genetic and personalized testing, also pose challenges that must be addressed to foster trust and ensure regulatory compliance.

Market Opportunities:

The clinical laboratory services market presents numerous growth opportunities through digital transformation, integration of artificial intelligence, and expansion into underserved regions. The increasing adoption of telemedicine and home-based sample collection services offers convenience and expands access to diagnostic testing. Emerging markets in Asia Pacific, Latin America, and Africa are investing in healthcare infrastructure, creating new avenues for laboratory services providers. Partnerships between public health agencies and private diagnostic labs to enhance disease surveillance and outbreak response further open doors for expansion. Moreover, the growing trend of preventive healthcare and wellness testing presents new service models and revenue streams for clinical laboratories.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the clinical laboratory services market globally?
• Which types of diagnostic services are seeing the highest demand across healthcare settings?
• How are automation and AI transforming the clinical laboratory services industry?
• Who are the major players in the clinical laboratory services market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future growth prospects for the global clinical laboratory services market?

Competitive Intelligence and Business Strategy:

Leading players in the global clinical laboratory services market, including Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, and Sonic Healthcare, are focused on expanding their geographic reach, enhancing test menus, and adopting cutting-edge diagnostic technologies. These companies invest in automation and digital platforms to streamline operations and deliver faster, more accurate results. Strategic mergers, acquisitions, and collaborations with hospitals and biotech firms help strengthen their market presence and expand their service offerings. Emphasis on customer-centric solutions, clinical expertise, and real-time diagnostics helps these players remain at the forefront of the evolving laboratory services landscape.

Key Companies Profiled:

• Laboratory Corporation of America Holdings (LabCorp)
• QIAGEN NV
• Charles River Laboratories International, Inc
• Eurofins Scientific SE
• Quest Diagnostics Incorporated
• OPKO Health, Inc
• Siemens Medical Solutions USA, Inc.
• NeoGenomics Laboratories
• Fresenius Medical Care
• ARUP Laboratories
• Sonic Healthcare
• SYNLAB International GmbH
• Mayo Clinic Laboratories
• Unilabs
• BioReference Laboratories, Inc.
• Genomic Health (part of Exact Sciences)
• Intertek Group plc
• ACM Global Laboratories
• Cerba HealthCare
• Medicover Diagnostics
• KingMed Diagnostics
• DaVita Clinical Research
• Amedes Holding GmbH
• Others

Market Segmentation

By Test Type

• Clinical Chemistry
• Medical Microbiology
• Genetic Testing
• Hematology
• Human and Tumor Genetics
• Cytology
• Others

By Provider Type

• Hospital laboratories
• Independent laboratories
• Reference laboratories

By Application

• Bioanalytical and Lab Chemistry Services
• Toxicology Testing Services
• Cell & Gene Therapy Related Services
• Drug Discovery & Development Services
• Preclinical & Clinical Trial Related Services
• Others

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Clinical Laboratory Services Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Service Adoption Analysis
• 3.3. Key Deals and Mergers
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Global Clinical Laboratory Services Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 4.3. Global Clinical Laboratory Services Market Outlook: Test Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019-2024
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
    • 4.3.3.1. Clinical Chemistry
    • 4.3.3.2. Medical Microbiology
    • 4.3.3.3. Genetic Testing
    • 4.3.3.4. Hematology
    • 4.3.3.5. Human and Tumor Genetics
    • 4.3.3.6. Cytology
    • 4.3.3.7. Others
  • 4.3.4. Market Attractiveness Analysis: Test Type
• 4.4. Global Clinical Laboratory Services Market Outlook: Provider Type
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Provider Type, 2019-2024
  • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Provider Type, 2025-2032
    • 4.4.3.1. Hospital laboratories
    • 4.4.3.2. Independent laboratories
    • 4.4.3.3. Reference laboratories
  • 4.4.4. Market Attractiveness Analysis: Provider Type
• 4.5. Global Clinical Laboratory Services Market Outlook: Application
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 4.5.3.1. Bioanalytical and Lab Chemistry Services
    • 4.5.3.2. Toxicology Testing Services
    • 4.5.3.3. Cell & Gene Therapy Related Services
    • 4.5.3.4. Drug Discovery & Development Services
    • 4.5.3.5. Preclinical & Clinical Trial Related Services
    • 4.5.3.6. Others
  • 4.5.4. Market Attractiveness Analysis: Application

5. Global Clinical Laboratory Services Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Clinical Laboratory Services Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Test Type
  • 6.2.3. By Provider Type
  • 6.2.4. By Application
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
  • 6.4.1. Clinical Chemistry
  • 6.4.2. Medical Microbiology
  • 6.4.3. Genetic Testing
  • 6.4.4. Hematology
  • 6.4.5. Human and Tumor Genetics
  • 6.4.6. Cytology
  • 6.4.7. Others
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Provider Type, 2025-2032
  • 6.5.1. Hospital laboratories
  • 6.5.2. Independent laboratories
  • 6.5.3. Reference laboratories
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 6.6.1. Bioanalytical and Lab Chemistry Services
  • 6.6.2. Toxicology Testing Services
  • 6.6.3. Cell & Gene Therapy Related Services
  • 6.6.4. Drug Discovery & Development Services
  • 6.6.5. Preclinical & Clinical Trial Related Services
  • 6.6.6. Others
• 6.7. Market Attractiveness Analysis

7. Europe Clinical Laboratory Services Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Test Type
  • 7.2.3. By Provider Type
  • 7.2.4. By Application
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
  • 7.4.1. Clinical Chemistry
  • 7.4.2. Medical Microbiology
  • 7.4.3. Genetic Testing
  • 7.4.4. Hematology
  • 7.4.5. Human and Tumor Genetics
  • 7.4.6. Cytology
  • 7.4.7. Others
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Provider Type, 2025-2032
  • 7.5.1. Hospital laboratories
  • 7.5.2. Independent laboratories
  • 7.5.3. Reference laboratories
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Bioanalytical and Lab Chemistry Services
  • 7.6.2. Toxicology Testing Services
  • 7.6.3. Cell & Gene Therapy Related Services
  • 7.6.4. Drug Discovery & Development Services
  • 7.6.5. Preclinical & Clinical Trial Related Services
  • 7.6.6. Others
• 7.7. Market Attractiveness Analysis

8. East Asia Clinical Laboratory Services Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Test Type
  • 8.2.3. By Provider Type
  • 8.2.4. By Application
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
  • 8.4.1. Clinical Chemistry
  • 8.4.2. Medical Microbiology
  • 8.4.3. Genetic Testing
  • 8.4.4. Hematology
  • 8.4.5. Human and Tumor Genetics
  • 8.4.6. Cytology
  • 8.4.7. Others
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Provider Type, 2025-2032
  • 8.5.1. Hospital laboratories
  • 8.5.2. Independent laboratories
  • 8.5.3. Reference laboratories
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Bioanalytical and Lab Chemistry Services
  • 8.6.2. Toxicology Testing Services
  • 8.6.3. Cell & Gene Therapy Related Services
  • 8.6.4. Drug Discovery & Development Services
  • 8.6.5. Preclinical & Clinical Trial Related Services
  • 8.6.6. Others
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Clinical Laboratory Services Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Test Type
  • 9.2.3. By Provider Type
  • 9.2.4. By Application
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
  • 9.4.1. Clinical Chemistry
  • 9.4.2. Medical Microbiology
  • 9.4.3. Genetic Testing
  • 9.4.4. Hematology
  • 9.4.5. Human and Tumor Genetics
  • 9.4.6. Cytology
  • 9.4.7. Others
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Provider Type, 2025-2032
  • 9.5.1. Hospital laboratories
  • 9.5.2. Independent laboratories
  • 9.5.3. Reference laboratories
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Bioanalytical and Lab Chemistry Services
  • 9.6.2. Toxicology Testing Services
  • 9.6.3. Cell & Gene Therapy Related Services
  • 9.6.4. Drug Discovery & Development Services
  • 9.6.5. Preclinical & Clinical Trial Related Services
  • 9.6.6. Others
• 9.7. Market Attractiveness Analysis

10. Latin America Clinical Laboratory Services Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Test Type
  • 10.2.3. By Provider Type
  • 10.2.4. By Application
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
  • 10.4.1. Clinical Chemistry
  • 10.4.2. Medical Microbiology
  • 10.4.3. Genetic Testing
  • 10.4.4. Hematology
  • 10.4.5. Human and Tumor Genetics
  • 10.4.6. Cytology
  • 10.4.7. Others
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Provider Type, 2025-2032
  • 10.5.1. Hospital laboratories
  • 10.5.2. Independent laboratories
  • 10.5.3. Reference laboratories
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Bioanalytical and Lab Chemistry Services
  • 10.6.2. Toxicology Testing Services
  • 10.6.3. Cell & Gene Therapy Related Services
  • 10.6.4. Drug Discovery & Development Services
  • 10.6.5. Preclinical & Clinical Trial Related Services
  • 10.6.6. Others
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Clinical Laboratory Services Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Test Type
  • 11.2.3. By Provider Type
  • 11.2.4. By Application
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
  • 11.4.1. Clinical Chemistry
  • 11.4.2. Medical Microbiology
  • 11.4.3. Genetic Testing
  • 11.4.4. Hematology
  • 11.4.5. Human and Tumor Genetics
  • 11.4.6. Cytology
  • 11.4.7. Others
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Provider Type, 2025-2032
  • 11.5.1. Hospital laboratories
  • 11.5.2. Independent laboratories
  • 11.5.3. Reference laboratories
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Bioanalytical and Lab Chemistry Services
  • 11.6.2. Toxicology Testing Services
  • 11.6.3. Cell & Gene Therapy Related Services
  • 11.6.4. Drug Discovery & Development Services
  • 11.6.5. Preclinical & Clinical Trial Related Services
  • 11.6.6. Others
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Laboratory Corporation of America Holdings (LabCorp)
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. QIAGEN NV
  • 12.3.3. Charles River Laboratories International, Inc
  • 12.3.4. Eurofins Scientific SE
  • 12.3.5. Quest Diagnostics Incorporated
  • 12.3.6. OPKO Health, Inc
  • 12.3.7. Siemens Medical Solutions USA, Inc.
  • 12.3.8. NeoGenomics Laboratories
  • 12.3.9. Fresenius Medical Care
  • 12.3.10. ARUP Laboratories
  • 12.3.11. Sonic Healthcare
  • 12.3.12. SYNLAB International GmbH
  • 12.3.13. Mayo Clinic Laboratories
  • 12.3.14. Unilabs
  • 12.3.15. BioReference Laboratories, Inc.
  • 12.3.16. Genomic Health (part of Exact Sciences)
  • 12.3.17. Intertek Group plc
  • 12.3.18. ACM Global Laboratories
  • 12.3.19. Cerba HealthCare
  • 12.3.20. Medicover Diagnostics
  • 12.3.21. KingMed Diagnostics
  • 12.3.22. DaVita Clinical Research
  • 12.3.23. Amedes Holding GmbH

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations

관련자료